Owens & Minor Inc
NYSE:ACH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/OCF
Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.
Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.
Valuation Scenarios
If P/OCF returns to its 3-Year Average (3), the stock would be worth $-5.47 (260% downside from current price).
| Scenario | P/OCF Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -1.9 | $3.42 |
0%
|
| 3-Year Average | 3 | $-5.47 |
-260%
|
| 5-Year Average | 4.6 | $-8.46 |
-347%
|
| Industry Average | 16.1 | $-29.32 |
-957%
|
| Country Average | 13.3 | $-24.34 |
-812%
|
Forward P/OCF
Today’s price vs future operating cash flow
Peer Comparison
| Market Cap | P/OCF | P/E | ||||
|---|---|---|---|---|---|---|
| US |
|
Owens & Minor Inc
NYSE:ACH
|
185.5m USD | -1.9 | -0.1 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
101.9B USD | 9.7 | 23.5 | |
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
60.4B USD | 14.1 | 37.2 | |
| US |
|
Cencora Inc
NYSE:COR
|
60.3B USD | 14.1 | 37.2 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
47.8B USD | 7.8 | 28.7 | |
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
31.9B AUD | 52.6 | 34.6 | |
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
61.9B CNY | 10.1 | 10.8 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
8.9B USD | 12.6 | 22.5 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
60B CNY | -3 060.4 | 21.2 | |
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | -320.2 | 89.6 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
57.7B HKD | 2.8 | 7.2 |
Market Distribution
| Min | 0 |
| 30th Percentile | 8.8 |
| Median | 13.3 |
| 70th Percentile | 20.1 |
| Max | 3 188 432.5 |
Other Multiples
Owens & Minor Inc
Glance View
Owens & Minor Inc., a stalwart within the healthcare industry, is distinguished by its unwavering commitment to ensuring the seamless flow of medical products. Born in the late 19th century, this company has weathered the evolving landscape of healthcare by steadfastly focusing on distribution and logistics. Its vast network delivers essential medical and surgical products to hospitals, integrated healthcare systems, and group purchasing organizations across the United States and beyond. The company's logistics expertise ensures that healthcare providers receive timely and reliable access to the products they need to save lives and improve patient care, making it a crucial artery in the healthcare supply chain. At the heart of Owens & Minor's financial engine is its ability to leverage economies of scale and a broad portfolio of products and services. The company generates revenue through the sales of medical supplies and devices, complemented by value-added services such as supply chain consulting and inventory management. By optimizing supply chains for its clients, Owens & Minor not only enhances operational efficiency but also creates long-term partnerships that are financially beneficial. Additionally, its Pratteln-based Byram Healthcare division has expanded their business into direct-to-patient distribution channels, focusing on unique needs like home healthcare and diabetes. By continually adapting to the shifting demands of the healthcare industry, Owens & Minor sustains its profitability while fostering innovation and resilience in its operations.
